Stat tweet of the morning for you all. After the Orioles were otherwordly in one-run games (and extra inning games) last year …
Which is obvious if you believe and understand most of what we know about one-run games: they tend to go either way and having a lights-out bullpen will give you an edge. Relievers not named Rivera and Kimbrel have a lot of one-year variance. The ball bounces one way this year and the other way next year.
I just seem to remember a lot of Orioles fans getting really, really upset last season if you dared suggest that the O’s record in one-run games was due to luck or a fluke or was otherwise not-sustainable. And I wonder what those folks think now.
The Angels signed Japanese superstar Shohei Ohtani for a $2.3 million signing bonus last weekend. They may have damaged goods on their hands. Jeff Passan of Yahoo Sports reports that Ohtani underwent a physical that revealed a first-degree sprain of his ulnar collateral ligament. As a result, he got a platelet-rich plasma injection on October 20. This was made known to teams after Ohtani entered MLB’s posting system, so it wasn’t like the Angels went into this blind.
Ohtani’s report said, “Although partial damage of UCL in deep layer of his right UCL exists, he is able to continue full baseball participation with sufficient elbow care program.” It also said Ohtani “will most likely be available to start his throwing program approximately a month from the PRP.”
Passan notes that the report also mentioned that a “small free body” floats in Ohtani’s elbow near his UCL.
Ohtani isn’t without other injuries. He battled hamstring and ankle issues throughout 2017 and underwent right ankle surgery back in October. Thankfully for the Angels, this diagnosis is about as good as it could be considering the circumstances. However, if Ohtani does exacerbate his UCL issue, he may ultimately need Tommy John surgery at some point, which would take him out of action for at least a year.